Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Olema Pharmaceuticals Inc (NASDAQ: OLMA) was $4.45 for the day, up 0.91% from the previous closing price of $4.41. In other words, the price has increased by $0.91 from its previous closing price. On the day, 0.63 million shares were traded. OLMA stock price reached its highest trading level at $4.67 during the session, while it also had its lowest trading level at $4.31.
Ratios:
Our analysis of OLMA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.10 and its Current Ratio is at 7.10. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on April 02, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 30, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $20.
On July 21, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $21.Oppenheimer initiated its Outperform rating on July 21, 2023, with a $21 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 08 ’25 when Bain Capital Life Sciences Inv bought 300,000 shares for $5.76 per share. The transaction valued at 1,727,370 led to the insider holds 7,800,000 shares of the business.
Graham G. Walmsley sold 700,761 shares of OLMA for $4,730,137 on Dec 17 ’24. The Director now owns 0 shares after completing the transaction at $6.75 per share. On Dec 13 ’24, another insider, Logos Opportunities Fund I LP, who serves as the Affiliate of the company, bought 700,761 shares for $6.75 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OLMA now has a Market Capitalization of 330383584 and an Enterprise Value of 41731844.
Stock Price History:
The Beta on a monthly basis for OLMA is 2.03, which has changed by -0.6147186 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, OLMA has reached a high of $16.62, while it has fallen to a 52-week low of $3.95. The 50-Day Moving Average of the stock is -14.57%, while the 200-Day Moving Average is calculated to be -55.08%.
Shares Statistics:
OLMA traded an average of 1.06M shares per day over the past three months and 725610 shares per day over the past ten days. A total of 57.29M shares are outstanding, with a floating share count of 54.63M. Insiders hold about 20.05% of the company’s shares, while institutions hold 84.42% stake in the company. Shares short for OLMA as of 1740700800 were 8466634 with a Short Ratio of 7.97, compared to 1738281600 on 8412251. Therefore, it implies a Short% of Shares Outstanding of 8466634 and a Short% of Float of 16.950001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
